China Automotive Systems, Inc. (NASDAQ:CAAS) reported a first-quarter FY23 sales growth of 4.3% year-on-year to $142.24 million, missing the consensus…
https://www.mdpi.com/1420-3049/28/6/2452
Abstract
The naphthalene diimide compound QN-302, designed to bind to G-quadruplex DNA sequences within the promoter regions of cancer-related genes, has high anti-proliferative
Relmada Therapeutics Inc (NASDAQ: RLMD) announced efficacy results for the de novo (or new to treatment) patients (204 patients) and safety results for all subjects (627 patients) from the Phase 3 trial (Study 310) of REL-1017 in patients with